Corline Biomedical AB (CLBIO) — Net Asset Quality Index
Corline Biomedical AB (CLBIO) has a Net Asset Quality Index of 86.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr115.97 Million minus total liabilities of Skr15.53 Million yields net assets of Skr100.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Corline Biomedical AB for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Corline Biomedical AB Net Asset Quality Index Over Time (2012–2025)
This chart shows how Corline Biomedical AB's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 86.6%, representing net assets of Skr100.45 Million against total assets of Skr115.97 Million SEK. For live market cap and overall valuation, see Corline Biomedical AB market capitalisation.
Annual Net Asset Quality Index for Corline Biomedical AB (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Corline Biomedical AB from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Corline Biomedical AB to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | Skr93.76 Million | Skr98.58 Million | Skr4.82 Million | ▲ +3.4 pp |
| 2024 | 91.7% | Skr86.91 Million | Skr94.76 Million | Skr7.85 Million | ▼ -1.5 pp |
| 2023 | 93.2% | Skr93.32 Million | Skr100.11 Million | Skr6.79 Million | ▲ +0.3 pp |
| 2022 | 92.9% | Skr94.59 Million | Skr101.78 Million | Skr7.19 Million | ▲ +2.2 pp |
| 2021 | 90.7% | Skr92.23 Million | Skr101.66 Million | Skr9.43 Million | ▲ +1.5 pp |
| 2020 | 89.3% | Skr52.03 Million | Skr58.28 Million | Skr6.25 Million | ▼ -3.8 pp |
| 2019 | 93.0% | Skr59.32 Million | Skr63.75 Million | Skr4.43 Million | ▲ +5.7 pp |
| 2018 | 87.4% | Skr54.96 Million | Skr62.91 Million | Skr7.95 Million | ▼ -1.9 pp |
| 2017 | 89.3% | Skr45.93 Million | Skr51.43 Million | Skr5.50 Million | ▼ -4.6 pp |
| 2016 | 93.9% | Skr38.75 Million | Skr41.27 Million | Skr2.53 Million | ▲ +8.9 pp |
| 2015 | 85.0% | Skr21.25 Million | Skr24.99 Million | Skr3.74 Million | ▲ +52.3 pp |
| 2014 | 32.7% | Skr5.48 Million | Skr16.77 Million | Skr11.29 Million | ▼ -25.4 pp |
| 2013 | 58.1% | Skr8.00 Million | Skr13.76 Million | Skr5.76 Million | ▲ +47.1 pp |
| 2012 | 11.0% | Skr1.37 Million | Skr12.46 Million | Skr11.09 Million | — |